A Patient-Reported Outcomes Analysis Of Lanreotide In The Treatment Of NETs Patients With Carcinoid Syndrome: Evidence From The ELECT Trial

A Patient-Reported Outcomes Analysis Of Lanreotide In The Treatment Of NETs Patients With Carcinoid Syndrome: Evidence From The ELECT Trial Article

authors

Vinik, Aaron I.

publication date

2019

webpage

Web of Science

published in

PATIENT-RELATED OUTCOME MEASURES Journal

keywords

NETs
lanreotide
neuroendocrine tumors
patient-reported outcomes

PubMed Central ID

PMC6825468

start page

335

end page

343

volume

10